Tara Carmack

709 total citations · 1 hit paper
9 papers, 501 citations indexed

About

Tara Carmack is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Tara Carmack has authored 9 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 4 papers in Hematology and 3 papers in Genetics. Recurrent topics in Tara Carmack's work include Systemic Lupus Erythematosus Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Tara Carmack is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Tara Carmack collaborates with scholars based in United States, Japan and Germany. Tara Carmack's co-authors include Amy M. DeLozier, Maria Silk, Matthew D. Linnik, Thomas Dörner, Kenneth Kalunian, Yoshiya Tanaka, Robert W. Hoffman, Richard Furie, Michelle Petri and Elisa Gómez and has published in prestigious journals such as The Lancet, Neurology and Annals of the Rheumatic Diseases.

In The Last Decade

Tara Carmack

8 papers receiving 494 citations

Hit Papers

Baricitinib for systemic lupus erythematosus: a double-bl... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
    2018 356 citations Daniel J. Wallace, Richard Furie et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Carmack United States 6 381 201 141 97 89 9 501
María López‐Lasanta Spain 11 160 0.4× 107 0.5× 56 0.4× 42 0.4× 63 0.7× 19 439
Sandra Goss United States 10 258 0.7× 114 0.6× 27 0.2× 65 0.7× 194 2.2× 16 453
Lina-Marcela Díaz-Gallo Sweden 16 193 0.5× 247 1.2× 74 0.5× 70 0.7× 25 0.3× 31 563
Eva Simmons-OʼBrien United States 6 109 0.3× 58 0.3× 182 1.3× 46 0.5× 112 1.3× 7 429
Maria Juárez United Kingdom 10 238 0.6× 159 0.8× 79 0.6× 96 1.0× 38 0.4× 20 506
Magdalena Szmyrka−Kaczmarek Poland 11 249 0.7× 172 0.9× 32 0.2× 88 0.9× 19 0.2× 27 395
Serghei Popa Moldova 7 174 0.5× 237 1.2× 60 0.4× 51 0.5× 61 0.7× 15 399
Francesca Trentin Italy 11 247 0.6× 152 0.8× 23 0.2× 54 0.6× 19 0.2× 23 362
Evripidis Kaltsonoudis Greece 11 230 0.6× 156 0.8× 27 0.2× 16 0.2× 67 0.8× 25 426
Sarah Fleischer Germany 11 172 0.5× 237 1.2× 28 0.2× 68 0.7× 18 0.2× 27 448

Countries citing papers authored by Tara Carmack

Since Specialization
Citations

This map shows the geographic impact of Tara Carmack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Carmack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Carmack more than expected).

Fields of papers citing papers by Tara Carmack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Carmack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Carmack. The network helps show where Tara Carmack may publish in the future.

Co-authorship network of co-authors of Tara Carmack

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Carmack. A scholar is included among the top collaborators of Tara Carmack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Carmack. Tara Carmack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hammer, Michael F., John M. Schreiber, Celene Grayson, et al.. (2022). Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey. Seizure. 97. 50–57. 9 indexed citations
2.
3.
Farber, Robert, et al.. (2021). Clinical development of valbenazine for tics associated with Tourette syndrome. Expert Review of Neurotherapeutics. 21(4). 393–404. 27 indexed citations
4.
Wallace, Daniel J., Richard Furie, Yoshiya Tanaka, et al.. (2018). Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. 392(10143). 222–231. 356 indexed citations breakdown →
5.
Genovese, Mark C., Joel M. Kremer, Douglas Schlichting, et al.. (2018). Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis. Lara D. Veeken. 57(5). 900–908. 45 indexed citations
6.
Wallace, Daniel J., Richard Furie, Yoshiya Tanaka, et al.. (2018). OP0019 Baricitinib in systemic lupus erythematosus (SLE): results from a phase 2, randomised, double-blind, placebo-controlled study. Annals of the Rheumatic Diseases. 77. 59–59. 2 indexed citations
7.
Schiff, Michael, Tsutomu Takeuchi, Roy Fleischmann, et al.. (2017). Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Arthritis Research & Therapy. 19(1). 208–208. 51 indexed citations
8.
Kay, Jonathan, Masayoshi Harigai, Yoshitaka Isaka, et al.. (2017). FRI0092 Effects of baricitinib on haemoglobin and related laboratory parameters in rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 76. 513–514. 6 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María López‐Lasanta Breakdown of academic impact, for papers by Sandra Goss Breakdown of academic impact, for papers by Lina-Marcela Díaz-Gallo Breakdown of academic impact, for papers by Eva Simmons-OʼBrien Breakdown of academic impact, for papers by Maria Juárez Breakdown of academic impact, for papers by Magdalena Szmyrka−Kaczmarek Breakdown of academic impact, for papers by Serghei Popa Breakdown of academic impact, for papers by Francesca Trentin Breakdown of academic impact, for papers by Evripidis Kaltsonoudis Breakdown of academic impact, for papers by Sarah Fleischer
Rankless by CCL
2026